Wedbush raises Palantir stock price target to $90
Wedbush analyst Daniel Ives raised the firm’s price target on Oklo (OKLO) to $45 from $26 and keeps an Outperform rating on the shares as the ...
Dan Ives, Wedbush, joins 'Fast Money' to talk the U.S.' infrastructure investment plans and what it means for Big Tech.
TikTok resumes operations in the U.S. after President-elect Trump promises a 90-day extension to the divest-or-sell law, ...
Wedbush Securities hiked its base case price target on Tesla (NASDAQ:TSLA) to $550 from $515 on its view that the golden age ...
Wedbush reduced their FY2024 earnings per share estimates for shares of Neurocrine Biosciences in a report released on ...
Shares of Nvidia, Microsoft, Oracle, and other AI-related companies surged Wednesday after the Trump administration’s ...
Wedbush Securities analysts predicted about 20% of the world’s population will access AI through an Apple device over the coming years.
Zentalis Pharmaceuticals Inc (ZNTL) stock saw a modest uptick, ending the day at $2.3 which represents a slight increase of $0.04 or 1.77% from the prior close of $2.26. The stock opened at $2.25 and ...
Netflix is entering 2025 “firing on all cylinders” after adding 19 million subscribers in the fourth quarter and raising its ...